NCPA: Biden’s drug program will fail if pharmacies are paid too little and too late
CMS’ failure to require timely, sufficient pharmacy reimbursement will lead to closures not seen since the start of Part D and patients will suffer as a result.
NCPA
CMS’ failure to require timely, sufficient pharmacy reimbursement will lead to closures not seen since the start of Part D and patients will suffer as a result.